Trust in the process: Hyperautomation for drug development accelerates time-to-market
AI and automation – often referred to as hyperautomation – are evolving rapidly with industry experts emphasizing their increasing ability to operate independently and make intelligent decisions. By combining powerful generative AI with business expertise, organizations can accelerate and streamline their processes like never before. I recently sat down with Mayank
